Navigation Links
Kettering in Medical News

DermTech Adds Allan C. Halpern, MD, Chief of Dermatology at Memorial Sloan- Kettering Cancer Center, to Company's Melanoma Advisory Board

LA JOLLA, Calif., March 5 /PRNewswire/ -- DermTech, a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, today announced that Allan C. Halpern, MD, has joined DermTech's Melanoma Advisory Board. Dr. Halpern is Chief of Dermatology at ...

Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer

...ma," says Gobin, who says that the study is the product of teamwork between New York Presbyterian Hospital and the Eye Cancer Center of Memorial Sloan kettering Cancer Center, New York City, with support from David Abramson, M.D., Brian Marr, M.D., Ira Dunkel, M.D. And Scott Brodie, M.D. Retinoblastoma,...

New drug candidate prolongs the lives of pancreatic cancer patients

...action of Ras in the tumor itself. For this study, Salirasib was licensed by Concordia Pharmaceuticals, which collaborated with the Memorial Sloan kettering Cancer Center, Johns Hopkins, the M.D. Anderson Cancer Center and other institutes in the United States. If Phase II/III trials are successful, Pro...

Promising medical trainees receive funding to pursue research in hematology

...dicine Andrew Marshall, Fox Chase Cancer Center Laura Myers, BA, Harvard Medical School, Brigham and Women's Hospital Jay Patel, BA, Memorial Sloan kettering Cancer Center Siayareh Rambally, BS, Baylor College of Medicine Katherine Ryken, University of Iowa College of Medicine Umar Salimi, BA, University...

Public Ready for Changes to Health-Care System But Unclear About Necessary Trade-Offs, Citizen Forums Suggest

...ustained, according to new research released today by Public Agenda and the kettering Foundation. The report, Public Thinking about Coping with the Cost of...zations, whose common interest is to promote public deliberation. kettering Foundation ( www.kettering.org ) is a research organization, focused on ...

Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology

... among the largest HIE's in the nation, with 8 of its 12 member hospitals operating in Manhattan, including Beth Israel Medical Center, Memorial Sloan kettering Hospital, Mount Sinai Medical Center, and New York Presbyterian Hospital. "The District of Columbia is leading the nation by example in its laun...

Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research

...r discovery of cancer genes, former director of the National Institutes of Health, and advisor to President Obama and Gates Foundation (Memorial Sloan kettering Cancer Center) Anthony S. Fauci , MD, global expert on HIV/AIDS and key advisor to the White House and Department of Health and Human Servic...

Aragon Pharmaceuticals Announces $8 Million Series A Financing

...aceuticals is a San Diego-based biopharmaceutical company built on the pioneering research of Charles Sawyers, M.D., an investigator at Memorial Sloan kettering Cancer Center and the Howard Hughes Medical Institute, and Michael Jung, Ph.D., a professor at UCLA , who are founders of Aragon. Their recent disco...

Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009

...089), a dual MET/VEGFR2 inhibitor, in metastatic gastric cancer (GC): Interim results of a multicenter phase II study." Dr. M. A. Shah, Memorial-Sloan kettering Cancer Center; Presentation on May 30. Breast Cancer: Investigational data on new biomarkers in TYKERB(R)/TYVERB(R) (lapatinib) ba...

ASGE recognizes 68 endoscopy units for quality and safety through endoscopy unit recognition program

...eat Neck Endoscopy, Great Neck, NJ Gulf Coast Endoscopy Center, Fort Meyers, FL Highland Endoscopy Center, Malvern, PA Huron Gastro, Ypsilanti, MI kettering Hospital GI Unit, Kettering, OH Kinston Medical Specialists P.A., Kinston, NC Lake Forest Endoscopy Center, LLC, Lake Forest, IL Lincoln Endoscopy ...
Kettering in Medical Technology

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

... by external grants. Ron Bentsur, Chief Executive Officer of Keryx Biopharmaceuticals, commented, "We're very excited that Memorial-Sloan kettering has taken on a leadership role in the first pediatric study of perifosine." Mr. Bentsur continued, "We are extremely grateful for the external finan...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... brain tumor models, in addition to assessment of angiogenesis inhibition potential. These placebo-controlled studies were conducted at Memorial Sloan kettering Cancer Center in New York as well as Duke University and the Piedmont Research Center, both in North Carolina. The tumor assessment studies were co...

Study Shows How Defective DNA Repair Triggers Two Neurological Diseases

...r authors of this paper include Erin Shull, Youngsoo Lee, Jingfeng Zhao and Helen Russell (St. Jude); John Petrini and Travis Stracker (Memorial Sloan kettering Cancer Center and Cornell University Graduate School of Medical Sciences); and Hironobu Nakane (formerly of St. Jude). This research was suppor...

IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program

...arcoma patients through a compassionate access study. The compassionate access study is being conducted initially at M. D. Anderson and Memorial-Sloan kettering Cancer Center in New York. "Patients are our first priority and we are committed to providing L-MTP- PE to those who desperately need treatment," sa...

IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study

...date with good quality of life." Study background The compassionate access study is being conducted initially at M. D. Anderson and Memorial-Sloan kettering Cancer Center in New York. Eligible patients will have a confirmed diagnosis of high grade osteosarcoma with relapsed or recurrent disease, locally or...

FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)

... shows early promise and may hold the key to better quality CAD diagnoses." Dr. Strauss is the Clinical Director of Nuclear Medicine at Memorial Sloan kettering Cancer Center and Professor of Radiology at Cornell University's Weill School of Medicine. "The FluoroPharma team is pleased and encouraged by the P...

IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients

...cularly when compared to the outcome of these patients for the last 20 years," said Dr. Meyers, vice chair, department of pediatrics at Memorial Sloan kettering Cancer Center and principal investigator of the Phase 3 trial. "These results are especially encouraging for the critically ill children and young adu...

IDM Pharma Announces Upcoming Clinical Data Presentations

...xorubicin, High Dose Methotrexate +/- Ifosfamide." Dr. Paul Meyers, principal investigator, vice chairman, department of pediatrics at Memorial Sloan kettering Cancer Center Abstract #780 The 39th Congress of International Society of Pediatric Oncology (SIOP) -- Mumbai, India Poster presentation -- Friday,...

AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer

...d vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial

...hemotherapy. Data from the ongoing trial in patients with solid tumors were presented on Friday, September 7, 2007 by Shanu Modi, M.D., Memorial Sloan kettering Cancer Center, in a poster, titled, "Alvespimycin (KOS-1022) and Trastuzumab (T): Activity in HER2+ Metastatic Breast Cancer (MBC)" at the 2007 Breast...
Kettering in Biological News

Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software

... MobileOffice(TM) Award from kettering Police Department Streamlines Incident and Crash Reporting WALL, N.J., July 1 /PRNewswire-FirstCall/ -- BIO-key International, ...

NYU and MSKCC research provides model for understanding chemically induced cancer initiation

... A team from the chemistry and biology departments of New York University, in collaboration with Memorial Sloan kettering Cancer Center (MSKCC), has uncovered a conformational switch--a change in shape in a carcinogen-damaged DNA site--in tumor suppressor genes altered by...

DuPont's first biologically derived polymer receives global recognition

...PE has membership of more than 20,000 plastics professionals in the United States and more than 70 countries around the world. Conference Chairman Tim kettering said, "The story of Sorona® is unique because it demonstrates that the use of renewable materials and processes can create new performance technologie...
Kettering in Biological Technology

Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors

...maintained an active faculty appointment, initially at Indiana University School of Medicine from 1997 to 1999 and, more recently, at Memorial Sloan kettering Cancer Center in New York from 2000 to 2008. Dr. Dhingra is currently heading KAPital Consulting LLC, a company dedicated to helping biotechnology, p...

AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences

... vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

AngioGenex Reviews 2008 Achievements and Sets Goals for 2009

... vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs

...d vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting

...e in patients with hepatocellular carcinoma (HCC) in Child-Pugh B (CPB) Cirrhosis? -- Ghassan Abou-Alfa, MD, internal medicine, Memorial Sloan kettering Cancer Center, New York, NY -- Poster 6, abstract #4518, poster discussion, Tuesday, June 3, 2008, 11 - 11:15 a.m., S406 -- Effica...

International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy

...e broad acceptance of RCM for the diagnosis of skin cancers and conditions. The Working Group founders include Dr. Salvador Gonzalez of Memorial Sloan kettering Cancer Center (New York) and Ramon y Cajal Hospital (Madrid); Dr. Giovanni Pellacani of University of Modena and Reggio Emilia; Dr. Josep Malvehy of H...

BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer

... leveraging its exciting product platform in DNA repair." Dr. Huh received his M.D. and Ph.D. from Cornell University Medical College/Memorial Sloan kettering Cancer Center and his A.B. from Dartmouth College. About BiPar Sciences BiPar Sciences, Inc. ( http://www.biparsciences.com ) is a clinical-stage ...

Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer

... Hill Hospital, his residency in internal medicine at the Mayo Clinic and a fellowship in medical oncology and clinical pharmacology at Memorial Sloan kettering Cancer Center. About Poniard Pharmaceuticals Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercia...

William Garland Joins AngioGenex's New Board of Directors

...es or proteins. The company's proprietary technology is based primarily on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City. His research established that the Id genes and proteins are required for the formation of the new blood vessel...

Abiant, Inc. Announces Close on Investment Round

...er, owner of the Maier Consulting Group and a former Senior Partner with Arthur Andersen, and Rick Mace, Vice President, Clinical Services Division of kettering Medical Center, have joined Abiant's Board of Directors as part of this Offering. We are excited about supporting a technology that will change the wa...
Kettering in Biological Dictionary

Computational biology

.... Department of Computational Biology ... for Computational Biology and Bioinfromatics ... Computational Biology Center. Memorial Sloan kettering Cancer Center ... The aim of computation biology is to build computer models that simulate ... Computational biology can help interpret detai...
Other Tags
(Date:12/15/2014)... December 15, 2014 Cancer researchers have ... underlying genetic causes of deadly malignant pleural mesothelioma. Surviving ... on their website. Click here to read it ... of Hawaii Cancer Center, and New York’s Langone Medical ... pleural mesothelioma patients in an effort to pinpoint ...
(Date:12/15/2014)... Palm Beach, FL (PRWEB) December 15, 2014 ... Care , knows that holidays can be a daze of ... From slips and falls while decking halls, to burns when ... plenty of holiday hazards that can happen at any time. ... for pain, MD Now has made a list of helpful ...
(Date:12/15/2014)... MA (PRWEB) December 15, 2014 ... management solutions, announced today that it has received ... Quality Assurance (NCQA) for its Disease Management (DM) ... pulmonary disease (COPD), coronary heart disease and diabetes. ... from NCQA for Health Dialog’s Disease Management (DM) ...
(Date:12/15/2014)... December 15, 2014 The increase in prevalence ... of the main factors which is contributing to the growth ... the diagnosis and treatment of hearing loss and balance disorders ... three parts - microphone, speaker and amplifier. The global market ... of 6.01% during the period from 2014 to 2019. Some ...
(Date:12/15/2014)... 2014 In support of high-quality ... to restrictive state laws that may have unintended ... important area of public health policy. , The ... Integrity of Independent Review, contends that state legislation ... peer review determinations can result in subpar outcomes ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock ... authentication solutions, and MorphoTrust USA (Safran), ... services, today announced a strategic partnership to offer ... motor vehicle administration (MVA), airport screening and financial ... identity-related solutions, MorphoTrust serves consumers through a nationwide ...
(Date:11/12/2014)... 12, 2014 Crossmatch™, a leading provider of ... ® fingerprint readers have been deployed throughout Montparnasse ... Central Mexico . The bakery chain implemented the ... issues caused by employees clocking in for each other. ... readers, Montparnasse relied on paper timecards and a mechanical ...
(Date:11/10/2014)... on U.S. store shelves in early 2010, and people ... small packets can be tossed into a washing machine ... powder. The convenience, though, has come with risks for ... Nationwide Children,s Hospital found that from 2012 through 2013, ... younger than 6 years of age swallowing, inhaling, or ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Study finds laundry detergent pods, serious poisoning risk for children 2
Other Contents